Zimmer Biomet Holdings (ZBH) Net Margin Growth (3y) (2012 - 2026)

Zimmer Biomet Holdings (ZBH) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -388.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -108.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,018.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1,978.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 399.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Zimmer Biomet Holdings 17.48 Bn 17.07 Bn 1.51 Bn -129.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -129.00
Mar 31, 2025 1,309.00
Dec 31, 2024 -2,528.00
Sep 30, 2024 1,465.00
Jun 30, 2024 1,265.00
Mar 31, 2024 885.00
Dec 31, 2023 239.00
Sep 30, 2023 -347.00
Jun 30, 2023 2,821.00
Mar 31, 2023 4,125.00
Mar 31, 2022 -1,600.00
Dec 31, 2021 4,129.00
Sep 30, 2021 -981.00
Jun 30, 2021 -934.00
Mar 31, 2021 -844.00
Dec 31, 2020 4,558.00
Sep 30, 2020 731.00
Jun 30, 2020 -2,642.00
Mar 31, 2020 -4,371.00
Dec 31, 2019 2,016.00